Rusterholz, DB; Dryer, SE; Long, JP; Barfknecht, CF; Mott, J. Sedative and analgesic actions of methoxylated 2-aminotetralins; involvement of α1- and α2-adrenoreceptors. Eur. J. Pharmacol., 25 Jul 1980, 65 (2–3), 201–211. 870 kB. https://doi.org/10.1016/0014-2999(80)90393-3 #Phenylephrine
Pawar, RS; Grundel, E. Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs). Drug Test. Anal., 1 Mar 2017, 9 (3), 500-517. 601 kB. https://doi.org/10.1002/dta.1980
Folen, VA. X-Ray powder diffraction data for some drugs, excipients, and adulterants in illicit samples. J. Forensic Sci., 1 Apr 1975, 20 (2), 348–372. 502 kB. https://doi.org/10.1520/JFS10282J #56 other
Kitlinski, LM; Harman, AL; Brousseau, MM; Skinner, HF. Reduction of phenylephrine via hydriodic acid-red phosphorus or iodine-red phosphorus: 3-Hydroxy-N-methylphenethylamine. JCLIC, 1 Jul 2006, 16 (3), 12-20. 109 kB. GC,MS,IR
Mesley, RJ; Evans, WH. Infrared identification of some hallucinogenic derivatives of tryptamine and amphetamine. J. Pharm. Pharmacol., 1 May 1970, 22 (5), 321–332. 775 kB. https://doi.org/10.1111/j.2042-7158.1970.tb08533.x #Phenylephrine IR
Kitlinski, LM; Harman, AL; Brousseau, MM; Skinner, HF. Reduction of phenylephrine with hydriodic acid/red phosphorus or iodine/red phosphorus: 3-Hydroxy-N-methylphenethylamine. Microgram J., 1 Jul 2005, 3 (3–4), 142–153. 529 kB. GC,MS,IR